Kirk Beebe, Ph.D.
Director of Application Science
Kirk Beebe has been an active scientist for over two decades with an interest in translating technological and method innovations to address fundamental biological questions. He received his Ph.D. in biochemistry from Ohio State University
where he advanced the understanding of substrate selection of mammalian signaling proteins by developing an innovative chemical biology approach. Following this, he was a post-doctoral scientist and senior research associate at the Scripps Research Institute where he and Professor Paul Schimmel uncovered mechanistic links between genetic code fidelity and disease. After initiating his industry career at Talecris Biotherapeutics (formerly Bayer HealthCare, Biological Products), Kirk joined Metabolon in 2007 and has emerged as a recognized leader for the application of metabolomics in translational research, oncology and frontiers such as the microbiome.